Modeling the population-level effects of male circumcision as an HIV-preventive measure: A gendered perspective

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Dushoff, Jonathan ^a   Patocs, Audrey ^a   Shi, Chyun Fung ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CIRCUMCISION; CONTROLLED STUDY; DISEASE TRANSMISSION; HEALTH BEHAVIOR; HEALTH PROMOTION; HETEROSEXUALITY; HIV TEST; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL MODEL; OUTCOME ASSESSMENT; PATIENT COUNSELING; POPULATION RESEARCH; PREVALENCE; SEX DIFFERENCE; SIMULATION; VALIDATION PROCESS; DISEASE COURSE; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PROBABILITY; REPRODUCTION; THEORETICAL MODEL; VIRUS LATENCY;

CIRCUMCISION, MALE; DISEASE PROGRESSION; FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HUMANS; MALE; MODELS, THEORETICAL; PROBABILITY; REPRODUCTION; SEX FACTORS; VIRUS LATENCY;

EID: 83755228600     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028608     Document Type: Article

References (40)

1. Joint United Nations Programme on HIV/AIDS (2010) UNAIDS Report on the Global AIDS Epidemic 2010 Geneva UNAIDS.
2. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, et al. (2010) Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 363: 2587-99.
3. Kort R, (2010) 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice- operations research. J Int AIDS Soc 13 (Suppl 1): S5.
4. Padian NS, McCoy SI, Karim SS, Hasen N, Kim J, et al. (2011) HIV prevention transformed: the new prevention research agenda. Lancet 378: 269-78.
5. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493-505.
6. Siegfried N, Muller M, Deeks JJ, Volmink J, (2009) Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev pp. CD003362.
7. World Health Organization (2007) New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications Geneva World Health Organization.
8. Auvert B, Taljaard D, Lagarde E, Tambekou J, Sitta R, et al. (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2: e298.
9. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. (2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369: 643-56.
10. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al. (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369: 657-66.
11. Kalichman S, Eaton L, Pinkerton S, (2007) Circumcision for HIV prevention: failure to fully account for behavioral risk compensation. PLoS Med 4: e138-author reply e146.
12. Cassell MM, Halperin DT, Shelton JD, Stanton D, (2006) Risk compensation: the Achilles' heel of innovations in HIV prevention? BMJ 332: 605-7.
13. Jackson DJ, Martin HL, Bwayo JJ, Nyange PM, Rakwar JP, et al. (1995) Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya. AIDS 9: 1279-83.
14. Crepaz N, Hart TA, Marks G, (2004) Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA 292: 224-36.
15. Sherr L, Lopman B, Kakowa M, Dube S, Chawira G, et al. (2007) Voluntary counselling and testing: uptake, impact on sexual behaviour, and HIV incidence in a rural Zimbabwean cohort. AIDS 21: 851-60.
16. Vinod Mishra, and Simona Bignami-Van Assche (2009) Concurrent sexual partnership and HIV infection: Evidence from national population-based surveys. DHS working paper, no. 62 Calverton, Maryland Marco International Press.
17. Agot KE, Kiarie JN, Nguyen HQ, Odhiambo JO, Onyango TM, et al. (2007) Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J Acquir Immune Defic Syndr 44: 66-70.
18. Matovu JK, Ssempijja V, Makumbi FE, Gray RH, Kigozi G, et al. (2007) Sexually transmitted infection management, safer sex promotion and voluntary HIV counselling and testing in the male circumcision trial, Rakai, Uganda. Reprod Health Matters 15: 68-74.
19. Andersson N, Cockcroft A, (2011) Male circumcision, attitudes to HIV prevention and HIV status: a cross-sectional study in Botswana, Namibia and Swaziland. AIDS Care.
20. Wawer MJ, Makumbi F, Kigozi G, Serwadda D, Watya S, et al. (2009) Circumcision in HIV- infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet 374: 229-37.
21. Weiss HA, Hankins CA, Dickson K, (2009) Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis. Lancet Infect Dis 9: 669-77.
22. Joint United Nations Programme on HIV/AIDS (2008) Report on global AIDS epidemic complete report Geneva UNAIDS.
23. Jewkes R, (2010) HIV/AIDS. Gender inequities must be addressed in HIV prevention. Science 329: 145-7.
24. Andersson N, Foster A, Mitchell S, Scheepers E, Goldstein S, (2007) Risk factors for domestic physical violence: national cross-sectional household surveys in eight southern African countries. BMC Womens Health 7: 11.
25. Group UE, (2009 Sep) Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med 6: e1000109.
26. Alsallaq RA, Cash B, Weiss HA, IML Jr, Omer SB, et al. (2009) Quantitative assessment of the role of male circumcision in HIV epidemiology at the population level. Epidemics 1: 139-152.
27. Hallett TB, Singh K, Smith JA, White RG, Raddad LJ, et al. (2008) Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One 3: e2212.
28. Bailey, NTJ, (1982) The Biomathematics of Malaria London and High Wycombe Charles Griffin and Co. Ltd.
29. Granich RM, Gilks CF, Dye C, De C, Williams BG, (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48-57.
30. Williams BG, Smith JO, Gouws E, Hankins C, Getz WM, et al. (2006) The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med 3: e262.
31. Podder CN, Sharomi O, Gumel AB, Moses S, (2007) To cut or not to cut: a modeling approach for assessing the role of male circumcision in HIV control. Bull Math Biol 69: 2447-66.
32. Nicolosi A, Correa L, Musicco M, Arici C, Gavazzeni G, et al. (1994) The efficiency of male-to-female and female-to-male sexual transmission of the human immunodefficiency virus: a study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission. Epidemiology 5: 570-5.
33. Melo MG, Santos BR, De C, Varella IS, Turella ML, et al. (2008) Sexual transmission of HIV-1 among serodiscordant couples in Porto Alegre, southern Brazil. Sex Transm Dis 35: 912-5.
34. Powers KA, Poole C, Pettifor AE, Cohen MS, (2008) Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis 8: 553-63.
35. Londish GJ, Murray JM, (2008) Significant reduction in HIV prevalence according to male circumcision intervention in sub-Saharan Africa. Int J Epidemiol 37: 1246-53.
36. R Development Core Team (downloaded 2008-2010). R project for statistical computing.http://www.r-project.org/.
37. Nagelkerke NJ, Moses S, de V, Bailey RC, (2007) Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis 7: 16.
38. Joint United Nations Programme on HIV/AIDS (2009) Country experiences in the scale-up of male circumcision in the Eastern and Southern Africa Region: Two years and counting Geneva UNAIDS.
39. World Health Organization (2009) World Health Statistics 2009: Mortality and burden of disease Geneva World Health Organization.
40. Todd J, Glynn JR, Marston M, Lutalo T, Biraro S, et al. (2007) Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 21 (Suppl 6): S55-63.